These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20194707)

  • 21. Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study.
    Marcovina SM; Albers JJ; Jacobs DR; Perkins LL; Lewis CE; Howard BV; Savage P
    Arterioscler Thromb; 1993 Jul; 13(7):1037-45. PubMed ID: 8318505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.
    Hatoum IJ; Nelson JJ; Cook NR; Hu FB; Rimm EB
    Am J Clin Nutr; 2010 Mar; 91(3):786-93. PubMed ID: 20107195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids.
    Schmidt EB; Koenig W; Khuseyinova N; Christensen JH
    Atherosclerosis; 2008 Jan; 196(1):420-424. PubMed ID: 17157859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity.
    Lu G; Chiem A; Anuurad E; Havel PJ; Pearson TA; Ormsby B; Berglund L
    Transl Res; 2007 Jun; 149(6):317-23. PubMed ID: 17543850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
    Onat A; Hergenç G; Can G; Uğur M; Nartop F
    Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States.
    Dahlén GH; Srinivasan SR; Stenlund H; Wattigney WA; Wall S; Berenson GS
    J Intern Med; 1998 Nov; 244(5):417-24. PubMed ID: 9845858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
    Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
    Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
    Tselepis AD; Panagiotakos DB; Pitsavos C; Tellis CC; Chrysohoou C; Stefanadis C
    Atherosclerosis; 2009 Sep; 206(1):303-8. PubMed ID: 19394616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
    Epps KC; Wilensky RL
    J Intern Med; 2011 Jan; 269(1):94-106. PubMed ID: 21054587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.
    Chung H; Kwon HM; Kim JY; Yoon YW; Rhee J; Choi EY; Min PK; Hong BK; Rim SJ; Yoon JH; Lee SJ; Park JK; Kim MH; Jo M; Yang JH; Lee BK
    Yonsei Med J; 2014 Nov; 55(6):1507-15. PubMed ID: 25323886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.
    Miller RG; Costacou T; Orchard TJ
    Diab Vasc Dis Res; 2010 Jan; 7(1):47-55. PubMed ID: 20368232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
    Caslake MJ; Packard CJ; Suckling KE; Holmes SD; Chamberlain P; Macphee CH
    Atherosclerosis; 2000 Jun; 150(2):413-9. PubMed ID: 10856534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.